Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Li, Haiying ^a   Sun, Liangliang ^a   Xu, Ying ^a   Li, Zixuan ^a   Luo, Wenting ^a   Tang, Zhongping ^a   Qiu, Xueshan ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PROTEIN MTA3; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG; CYCLINE; MTA3 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MTA3 GENE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; DISEASE COURSE; DOWN REGULATION; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLINS; DISEASE PROGRESSION; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84879248517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066679     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5)p.: 277-300.
2. Minna JD, Roth JA, Gazdar AF, (2002) Focus on lung cancer. Cancer Cell 1(1)p.: 49-52.
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346(2)p.: 92-98.
4. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6)p.: 453-458.
5. Hunter K, Welch DR, Liu ET, (2003) Genetic background is an important determinant of metastatic potential. Nat Genet 34(1)p.: 23-24; author reply 25.
6. Pencil SD, Toh Y, Nicolson GL, (1993) Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat 25(2)p.: 165-174.
7. Toh Y, Pencil SD, Nicolson GL, (1994) A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269(37)p.: 22958-22963.
8. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL, (1998) Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395(6705)p.: 917-921.
9. Xue Y, Wong J, Moreno GT, Young MK, Cote J, et al (1998) NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell. 2(6)p.: 851-861.
10. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, et al (1999) Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet. 23(1)p.: 62-66.
11. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, et al (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13(15)p.: 1924-1935.
12. Humphrey GW, Wang Y, Russanova VR, Hirai T, Qin J, et al (2001) Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem 276(9)p.: 6817-6824.
13. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, et al (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113(2)p.: 207-219.
14. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, et al (2004) MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119(1)p.: 75-86.
15. Bruning A, Juckstock J, Blankenstein T, Makovitzky J, Kunze S, et al (2010) The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas. Histol Histopathol 25(11)p.: 1447-1456.
16. Zhang H, Stephens LC, Kumar R, (2006) Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clin Cancer Res 12(5)p.: 1479-1486.
17. Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, et al (2008) The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther 7(9)p.: 1460-1467.
18. Zhang H, Singh RR, Talukder AH, Kumar R, (2006) Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes Dev. 20(21)p.: 2943-2948.
19. Kwintkiewicz J, Padilla-Banks E, Jefferson WN, Jacobs IM, Wade PA, et al (2012) Metastasis-associated protein 3 (MTA3) regulates G2/M progression in proliferating mouse granulosa cells. Biol Reprod 86(3)p.: 1-8.
20. Mylonas I, Bruning A, (2012) The metastasis-associated gene MTA3 is an independent prognostic parameter in uterine non-endometrioid carcinomas. Histopathology. 60(4)p.: 665-670.
21. Bruning A, Makovitzky J, Gingelmaier A, Friese K, aMylonas I, (2009) The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells. Histochem Cell Biol. 132(1)p.: 33-38.
22. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES, (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 25(11)p.: 1620-1628.
23. Roy PG, Thompson AM, (2006) Cyclin D1 and breast cancer. Breast. 15(6)p.: 718-727.
24. Ratschiller D, Heighway J, Gugger M, Kappeler A, Pirnia F, et al (2003) Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol. 21(11)p.: 2085-2093.
25. Keum JS, Kong G, Yang SC, Shin DH, Park SS, et al (1999) Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer. 81(1)p.: 127-132.
26. Yam CH, Fung TK, Poon RY, (2002) Cyclin A in cell cycle control and cancer. Cell Mol Life Sci. 59(8)p.: 1317-1326.
27. D'Angiolella V, Grieco D, (2004) Attach first, then detach: a role for cyclin B-dependent kinase 1 in coordinating proteolysis with spindle assembly. Cell Cycle 3(2)p.: 132-133.